Ombitasvir (ABT 267), Ritanavir Boost with Dastasbuvir (ABT 333) and Prataspravir (ABT 450) with or without Ribavirin (RBV) in G1 Special Population in Hemodialysis (HD) in Chronic Hepatitixs C (HCV) Patients Drop C Trial